bone
-
Hospitals
Bone Therapeutics announces further positive efficacy in ALLOB® Phase I/IIA delayed-union fracture trial
May 17, 2016 BONE THERAPEUTICS (Brussels:BOTHE) (Paris:BOTHE) (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high…
Read More » -
Extremities
First Ray Receives FDA 510(k) Clearance for CortiClamp™ Small Bone Fixation System
LOGAN, Utah, May 16, 2016 /PRNewswire/ — First Ray, a start-up medical device company focused on advanced surgical devices for improving outcomes for…
Read More » -
Spine
Misonix Features New BoneScalpel® MIS at SpineWeek 2016 In Singapore
FARMINGDALE, N.Y., May 16, 2016 /PRNewswire/ — Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic…
Read More » -
Spine
Bone Therapeutics completes recruitment of its ALLOB® Phase IIA spinal fusion study
BONE THERAPEUTICS, (Brussels:BOTHE) (Paris:BOTHE) (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in…
Read More » -
Spine
New Research Confirms bioDensity™ as a Safe Alternative to High Impact Activity in Rebuilding Bone Density
MÁLAGA, Spain–(BUSINESS WIRE)–At the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases,Performance Health Systems presented new research on April 17,…
Read More » -
Financial
Bone Biologics Completes $5.75 Million Round Of Financing
BOSTON, /PRNewswire/ — Bone Biologics (OTCQB: BBLG), an orthobiologic company focused on regenerative medicine, announced today the completion of a $5.75…
Read More » -
Spine
New Bone Graft Aims to Make Fusions of the Neck Stronger
Posted in Medical Device Business by Arundhati Parmar Cerapedics has developed the only FDA-approved bone graft approved for the…
Read More » -
Spine
Medtronic Responds to Star Tribune Article Regarding INFUSE Bone Graft
MINNEAPOLIS – April 10, 2016 – This weekend, an article was published in the Minneapolis Star Tribune that criticized Medtronic’s…
Read More » -
Financial
Bone Therapeutics Reports Full Year 2015 Results
GOSSELIES, Belgium–(BUSINESS WIRE)– Regulatory News: BONE THERAPEUTICS (Brussels:BOTHE) (Paris:BOTHE) (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing…
Read More » -
Biologics
Bone Therapeutics Reports Initial Efficacy Results from Its PREOB® Phase IIA Trial in Severe Osteoporosis
BONE THERAPEUTICS (Brussels:BOTHE) (Paris:BOTHE) (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in…
Read More » -
Biologics
New Resorbable Bioceramic Materials for Bone Fractures Might Soon Enter the Market
BARCELONA, Spain–(BUSINESS WIRE)–RESTORATION, an European research project, has developed new resorbable bioceramic materials that can be used in three different…
Read More » -
Extremities
MicroPort Orthopedics Launches Profemur Preserve Hip Stem
ARLINGTON, Tenn.–(BUSINESS WIRE)–MicroPort Orthopedics Inc. (“MicroPort Orthopedics”) announced today the launch of the Profemur® Preserve® Hip Stem (“Profemur® Preserve®”), a…
Read More » -
Biologics
Bacterin Announces the Launch of ArthroFuse(TM)
BELGRADE, Mont., June 3, 2015 (GLOBE NEWSWIRE) — Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary…
Read More » -
Biologics
New reporter system to study bone-related regenerative medicine generated by UMN labs
A new reporter system used to study the bone regeneration potential of human embryonic stem cells has been generated in research led…
Read More » -
Extremities
Osteoporosis: balancing bone formation and degradation
Most existing treatments for pathological bone loss inhibit osteoclasts (bone-destroying cells) to limit bone degradation. However, by doing this, they…
Read More »